Where will it end? Pathways to care and catastrophic costs following negative TB evaluation in Uganda.
Thomas H A SamuelsPriya B SheteChris OjokTalemwa NalugwaKatherine FarrStavia TuryahabweAchilles KatambaAdithya CattamanchiDavid A J MoorePublished in: PloS one (2021)
Patients with TB symptoms who experience financial catastrophe after negative TB evaluation may represent a larger absolute number of patients than those suffering from costs due to TB. They may not be captured by existing definitions of non-TB catastrophic health expenditure.